methods hsxz decoction was administered to the patients with unstable angina pectoris for 12 weeks.
方法采用化湿泄浊汤治疗不稳定心绞痛,疗程为12周,分别于治疗前后检测hs-crp一次。
objective: to investigate the clinical effectiveness of prolonged low-dose urine plasminogen activator(u-pa)therapy in patients with unstable angina pectoris (uap).
目的:观察小剂量长疗程尿纤溶酶原激活物(u-pa)治疗不稳定型心绞痛(uap)的临床疗效。
methods the first platelet aggregation test(pat) was immediately done when 118 patients with unstable angina pectoris were admitted to hospital.
方法 选择不稳定性心绞痛患者118例,于入院即刻行血小板聚集率测定;
objective to valuate the clinical significance of serum troponin i (ctni) in patients with unstable angina pectoris and minor myocardial damage (mmd).
目的为了评价血清心肌肌钙蛋白i测定对不稳定型心绞痛患者微小心肌损伤的诊断及预后判断的临床意义。
methods hsxz decoction was administered to the patients with unstable angina pectoris for 12 weeks. hs-crp was detected before and after the administration.
方法采用化湿泄浊汤治疗不稳定心绞痛,疗程为12周,分别于治疗前后检测hs-crp一次。